ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Adult Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,892Medicare Part D Prescriptions Filled, Including Refills

Rank: 10 out of 47

$651K Total Retail Price of All Prescriptions

Rank: 8 out of 47

433 Patients Receiving at Least One Drug in Part D
64%Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 433 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

7% of this provider’s 433 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 5,167 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$73 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 25.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
PRAVASTATIN SODIUM 352 246 1 14
AMLODIPINE BESYLATE 325 239 2 3
OMEPRAZOLE 314 151 3 5
METOPROLOL TARTRATE 250 211 4 6
LISINOPRIL 235 187 5 2
METFORMIN HCL 229 144 6 8
LEVOTHYROXINE SODIUM 227 157 7 4
LISINOPRIL-HYDROCHLOROTHIAZIDE 181 152 8 21
SIMVASTATIN 177 141 9 1
GABAPENTIN 161 67 10 15
FUROSEMIDE 144 104 11 7
ATORVASTATIN CALCIUM 130 88 12 11
HYDROCHLOROTHIAZIDE 119 102 13 10
ENDOCET 115 45 S2 14 51
FLUTICASONE PROPIONATE 114 70 15 55
ATENOLOL 114 103 15 12
PREDNISONE 109 56 17 71
OXYCODONE-ACETAMINOPHEN 108 45 S2 18 66
WARFARIN SODIUM 94 73 19 13
FAMOTIDINE 91 39 20 46
MORPHINE SULFATE ER 89 28 S2 21 141
CYMBALTA 88 23 22 96
METOPROLOL SUCCINATE 85 54 23 20
LOSARTAN POTASSIUM 79 64 24 37
ZOLPIDEM TARTRATE 79 42 24 16
TRAMADOL HCL 78 33 26 18
OXYCODONE HCL 75 18 S2 27 38
ADVAIR DISKUS 75 44 27 40
TRAZODONE HCL 74 12 29 48
OXYCODONE HCL-ACETAMINOPHEN 72 48 S2 30 127
ZETIA 72 40 30 94
ALENDRONATE SODIUM 70 44 32 32
HYDROCODONE-ACETAMINOPHEN 70 45 S3 32 9
LOVASTATIN 69 69 34 33
CITALOPRAM HBR 69 13 34 24
VENTOLIN HFA 69 20 34 43
CLOPIDOGREL 67 38 37 29
ALLOPURINOL 64 54 38 36
LANTUS 61 39 39 60
LOSARTAN-HYDROCHLOROTHIAZIDE 61 55 39 105
SERTRALINE HCL 58 18 41 28
CIPROFLOXACIN HCL 56 35 42 90
AMOXICILLIN 55 17 43 110
COMBIVENT 54 39 44 134
CARVEDILOL 54 36 44 27
NEXIUM 51 35 46 19
FENOFIBRATE 51 39 46 78
PAROXETINE HCL 51 22 46 63
FENTANYL 50 29 S2 49 88
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 20, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.